Launch event of the RETHINKING Alzheimer's disease White Paper Virtual event
24.01.23 - 24.01.23
Launch event of the RETHINKING Alzheimer's disease White Paper
Registrations are now open.
Save the date: Launch event of the RETHINKING Alzheimer's disease White Paper.
The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis”. This paper is the first of EBC’s “RETHINKING Alzheimer’s disease” project, looking at how to improve the detection, diagnosis, care and monitoring of AD.
The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis”. This paper is the first of EBC’s “RETHINKING Alzheimer’s disease” project, looking at how to improve the detection, diagnosis, care and monitoring of AD.
The White Paper is particularly looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment – MCI – stage) and what new care pathways would need to be implemented to reach out to patients at that stage. With disease modifying treatments targeting patients with MCI potentially coming to market in the near future, it is also important to see how prepared healthcare systems are to provide these new treatments.
Learn more about the RETHINKING Alzheimer's disease project.